Kenya Business News API

{
    "totalArticles": 1937,
    "articles": [
        {
            "id": "b1d86daf2fe02a815fdd2927da6d4488",
            "title": "Bone Regeneration Technology Used in First Patient Surgery",
            "description": "The first clinical use of Professor Guillermo Ameer’s citrate-based biomaterial marks a major milestone in regenerative engineering.",
            "content": "A bone regeneration device using bioactive materials pioneered by Querrey Simpson Institute for Regenerative Engineering at Northwestern University (QSI RENU) director Guillermo Ameer was recently used in its first surgical case, Acuitive Technologie... [1622 chars]",
            "url": "https://www.mccormick.northwestern.edu/news/articles/2025/12/bone-regeneration-technology-used-in-first-patient-surgery/",
            "image": "https://www.mccormick.northwestern.edu/images/news/2025/12/bone-regeneration-technology-used-in-first-patient-surgery-social.jpg",
            "publishedAt": "2025-12-05T21:23:56Z",
            "lang": "en",
            "source": {
                "id": "8b45cbfa73c292c2951d6ec156c2825a",
                "name": "Northwestern University",
                "url": "https://www.mccormick.northwestern.edu"
            }
        },
        {
            "id": "cab0d6b5595752859525db44f9545cb8",
            "title": "New York Times sues AI startup for ‘illegal’ copying of millions of articles",
            "description": "Perplexity AI also faces lawsuit from Murdoch-owned Dow Jones and New York Post for its use of copyrighted content",
            "content": "The New York Times sued an embattled artificial intelligence startup on Friday, accusing the firm of illegal copying of millions of articles. The newspaper alleged Perplexity AI had distributed and displayed journalists’ work without permission en ma... [2700 chars]",
            "url": "https://www.theguardian.com/technology/2025/dec/05/new-york-times-perplexity-ai-lawsuit",
            "image": "https://i.guim.co.uk/img/media/e836b3c9d9a0ed03c33364b86e05b0fe9c173305/342_0_3423_2739/master/3423.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&precrop=40:21,offset-x50,offset-y0&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=dfe7d1f09b37a1c28ecaffc3579f0752",
            "publishedAt": "2025-12-05T18:21:00Z",
            "lang": "en",
            "source": {
                "id": "558a003a7a0164e924408edec7e99f99",
                "name": "The Guardian",
                "url": "https://www.theguardian.com"
            }
        },
        {
            "id": "a9792f04389fa62244a398d2c8423251",
            "title": "Albemarle jumps after UBS upgrades to 'buy'",
            "description": "** Shares of chemical producer Albemarle NYSE:ALB rise 6.60% to $127.03** UBS upgrades shares of ALB to \"buy\" from \"neutral,\" expecting lithium prices to rise as the market shifts into a supply deficit starting in the second half of 2026** Brokerage also raised PT to $185 from $107, which is a 55.3…",
            "content": "** Shares of chemical producer Albemarle ALB rise 6.60% to $127.03\n** UBS upgrades shares of ALB to \"buy\" from \"neutral,\" expecting lithium prices to rise as the market shifts into a supply deficit starting in the second half of 2026\n** Brokerage als... [414 chars]",
            "url": "https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3XB1DW:0-albemarle-jumps-after-ubs-upgrades-to-buy/",
            "image": "https://s.tradingview.com/static/images/illustrations/news-story.jpg",
            "publishedAt": "2025-12-05T18:01:14Z",
            "lang": "en",
            "source": {
                "id": "1502c84dba0658eaf3785139abd32531",
                "name": "TradingView",
                "url": "https://www.tradingview.com"
            }
        }
    ]
}